BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33123246)

  • 1. KDM3A regulates Slug expression to promote the invasion of MCF7 breast cancer cells in hypoxia.
    Ahn HJ; Moon B; Park M; Kim JA
    Oncol Lett; 2020 Dec; 20(6):335. PubMed ID: 33123246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.
    Ramadoss S; Guo G; Wang CY
    Oncogene; 2017 Jan; 36(1):47-59. PubMed ID: 27270439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysine demethylase 3A in hypoxic macrophages promotes ovarian cancer development through regulation of the vascular endothelial growth factor A/Akt signaling.
    Song Y; Li L; Xi Y
    Tissue Cell; 2023 Dec; 85():102253. PubMed ID: 37890327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Knockdown of lysine-specific demethylase 3A (KDM3A) inhibits the invasion and migration of MDA-MB-231 breast cancer cells and arrests the cell cycle in the G0/G1 phase].
    Gao W; Zhang T; Yao J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Sep; 37(9):808-814. PubMed ID: 34533128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis.
    Lin CW; Wang LK; Wang SP; Chang YL; Wu YY; Chen HY; Hsiao TH; Lai WY; Lu HH; Chang YH; Yang SC; Lin MW; Chen CY; Hong TM; Yang PC
    Nat Commun; 2016 Dec; 7():13867. PubMed ID: 28004751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockout of KDM3A in MDA-MB-231 breast cancer cells inhibits tumor malignancy and promotes apoptosis.
    Han Y; Maimaiti N; Sun Y; Yao J
    J Mol Histol; 2024 Feb; 55(1):139-148. PubMed ID: 38165573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of NURP1 in temozolomide resistance in hypoxia-treated glioma cells via the KDM3A/TFEB axis.
    Li T; Fu X; Wang J; Shang W; Wang X; Zhang L; Li J
    Oncol Res; 2023; 31(3):345-359. PubMed ID: 37305393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXA1 Induces E-Cadherin Expression at the Protein Level via Suppression of Slug in Epithelial Breast Cancer Cells.
    Anzai E; Hirata K; Shibazaki M; Yamada C; Morii M; Honda T; Yamaguchi N; Yamaguchi N
    Biol Pharm Bull; 2017; 40(9):1483-1489. PubMed ID: 28867731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KDM3A Senses Oxygen Availability to Regulate PGC-1α-Mediated Mitochondrial Biogenesis.
    Qian X; Li X; Shi Z; Bai X; Xia Y; Zheng Y; Xu D; Chen F; You Y; Fang J; Hu Z; Zhou Q; Lu Z
    Mol Cell; 2019 Dec; 76(6):885-895.e7. PubMed ID: 31629659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The histone H3K9 demethylase KDM3A promotes anoikis by transcriptionally activating pro-apoptotic genes BNIP3 and BNIP3L.
    Pedanou VE; Gobeil S; Tabariès S; Simone TM; Zhu LJ; Siegel PM; Green MR
    Elife; 2016 Jul; 5():. PubMed ID: 27472901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone inhibits hypoxia-induced epithelial-mesenchymal transition in colon cancer.
    Kim JH; Hwang YJ; Han SH; Lee YE; Kim S; Kim YJ; Cho JH; Kwon KA; Kim JH; Kim SH
    World J Gastroenterol; 2015 Sep; 21(34):9887-99. PubMed ID: 26379394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KDM3A is associated with tumor metastasis and modulates colorectal cancer cell migration and invasion.
    Liu J; Liang T; Zhangsun W
    Int J Biol Macromol; 2019 Apr; 126():318-325. PubMed ID: 30578902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone Demethylase KDM3 (JMJD1) in Transcriptional Regulation and Cancer Progression.
    Fan L; Sudeep K; Qi J
    Adv Exp Med Biol; 2023; 1433():69-86. PubMed ID: 37751136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic change of chromatin conformation in response to hypoxia enhances the expression of GLUT3 (SLC2A3) by cooperative interaction of hypoxia-inducible factor 1 and KDM3A.
    Mimura I; Nangaku M; Kanki Y; Tsutsumi S; Inoue T; Kohro T; Yamamoto S; Fujita T; Shimamura T; Suehiro J; Taguchi A; Kobayashi M; Tanimura K; Inagaki T; Tanaka T; Hamakubo T; Sakai J; Aburatani H; Kodama T; Wada Y
    Mol Cell Biol; 2012 Aug; 32(15):3018-32. PubMed ID: 22645302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KDM3A-mediated demethylation of histone H3 lysine 9 facilitates the chromatin binding of Neurog2 during neurogenesis.
    Lin H; Zhu X; Chen G; Song L; Gao L; Khand AA; Chen Y; Lin G; Tao Q
    Development; 2017 Oct; 144(20):3674-3685. PubMed ID: 29042477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lutein inhibits proliferation, invasion and migration of hypoxic breast cancer cells via downregulation of HES1.
    Li Y; Zhang Y; Liu X; Wang M; Wang P; Yang J; Zhang S
    Int J Oncol; 2018 Jun; 52(6):2119-2129. PubMed ID: 29620169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.
    Wilson S; Fan L; Sahgal N; Qi J; Filipp FV
    Oncotarget; 2017 May; 8(18):30328-30343. PubMed ID: 28416760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation.
    Nakatsuka T; Tateishi K; Kudo Y; Yamamoto K; Nakagawa H; Fujiwara H; Takahashi R; Miyabayashi K; Asaoka Y; Tanaka Y; Ijichi H; Hirata Y; Otsuka M; Kato M; Sakai J; Tachibana M; Aburatani H; Shinkai Y; Koike K
    Oncogene; 2017 Nov; 36(45):6262-6271. PubMed ID: 28692045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single factors alone can induce mesenchymal-like morphology, but not promote full EMT in breast cancer cell lines with different hormone statuses.
    Tveitarås MK; Reigstad I; Leiss L; Reed RK; Stuhr L
    Exp Cell Res; 2017 Oct; 359(1):257-265. PubMed ID: 28734865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.